Bladder cancer: open trials in Czechia

8 open trials have a site in Czechia. Registry data; only the trial team decides who can take part.

NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Fakultni nemocnice Hradec Kralove, Hradec Králové · Fakultni nemocnice Olomouc, Olomouc · Fakultni Thomayerova nemocnice, Prague · Fakultni nemocnice v Motole, Prague · Vseobecna fakultni nemocnice v Praze, Prague
Registry updated 2026-11-03
NCT06510374
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 3 · Ferring Pharmaceuticals
Kromerizska Nemocnice A S, Kroměříž · Krajska nemocnice Liberec a.s., Liberec I-Stare Mesto · Fakultni Thomayerova nemocnice, Prague · Androgeos spol. s r.o., Prague 6
Registry updated 2026-10-30
NCT06545955
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 3 · Ferring Pharmaceuticals
Kromerizska Nemocnice A S, Kroměříž · Krajska nemocnice Liberec a.s., Liberec I-Stare Mesto · Fakultni Thomayerova nemocnice, Prague · Fakultni nemocnice v Motole, Prague · Androgeos spol. s r.o., Prague 6
Registry updated 2026-10-30
2024-516906-47-00
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Trial Treatment · Phase 2/3 · Daiichi Sankyo Inc.
University Hospital Olomouc, Olomouc · Fakultni Nemocnice Motol a Homolka, Prague · Vseobecna Fakultni Nemocnice V Praze, Prague 2
Registry updated 2026-10-29
NCT07218380
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Trial Treatment · Phase 3 · Eli Lilly and Company
Masarykuv onkologicky ustav, Brno · Fakultni nemocnice Hradec Kralove, Hradec Králové · Fakultni nemocnice Olomouc, Olomouc · Fakultni nemocnice Motol, Prague · Fakultni Thomayerova nemocnice, Prague · Fakultni nemocnice Kralovske Vinohrady, Prague
Registry updated 2026-10-07
NCT07804056
A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 3 · Hamlet Pharma AB
Fakultni Nemocnice Motol a Homolka, Prague
Registry updated 2026-09-21
NCT05303532
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
Trial Treatment · Phase 3 · Astrazeneca AB
University Hospital Olomouc, Olomouc
Registry updated 2026-09-08
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Brno · Hradec Králové · Prague
Registry updated 2026-07-29

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error